New Research Poster Presentation 5.32
A New Formulation of Methylphenidate: Phase 3 Study of the Efficacy and Tolerability of an Extended-Release Orally Disintegrating Tablet in Children 6-12 Years of Age With ADHD

Friday, October 30, 2015 12:30 PM
Ann Catherine Childress, MD, Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Scott H. Kollins, PhD, Duke University Medical Center, Durham, NC
Andrew Cutler, MD, Florida Clinical Research Center, LLC, Bradenton, FL
Andrea Marraffino, PhD, Florida Clinical Research Center, Lakeside Behavioral Healthcare, Orlando, FL
Carolyn R. Sikes, PhD, Clinical Affairs, NEOS Therapeutics Inc., Grand Prairie, TX
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.